In one recent HTS, patient-derived glioblastoma (GBM) spheroid models were used to identify drivers of GBM progression and therapeutic targets relevant to both NF1-mutant and NF1-WT tumors [136]. The gene discussed is NF1; the disease is glioblastoma.